The Food and Drug Administration (FDA) is requesting approval from the Office of Management and Budget (OMB) for information collection requirements contained in 21 CFR, Part 812. The IDE regulation permits a device to be shipped in interstate commerce for clinical investigation to determine its medical safety and effectiveness. Although the IDE regulations exempts the device from certain requirements of the Act, it requires safeguards for humans who are subjects of investigations; maintenance of sound ethical standards; and procedures to assure development of reliable scientific data.
The latest form for Investigational Device Exemptions expires 2022-11-30 and can be found here.
Document Name |
---|
Supporting Statement A |
Justification for No Material/Nonsubstantive Change |
Justification for No Material/Nonsubstantive Change |
Federal Enterprise Architecture: Health - Consumer Health and Safety